192 related articles for article (PubMed ID: 35052535)
21. Fractalkine, sICAM-1 and Kynurenine Pathway in Restrictive Anorexia Nervosa-Exploratory Study.
Dudzińska E; Szymona K; Kloc R; Kocki T; Gil-Kulik P; Bogucki J; Kocki J; Paduch R; Urbańska EM
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33498837
[TBL] [Abstract][Full Text] [Related]
22. Antioxidant properties of xanthones from Calophyllum brasiliense: prevention of oxidative damage induced by FeSO₄.
Blanco-Ayala T; Lugo-Huitrón R; Serrano-López EM; Reyes-Chilpa R; Rangel-López E; Pineda B; Medina-Campos ON; Sánchez-Chapul L; Pinzón E; Cristina TS; Silva-Adaya D; Pedraza-Chaverrí J; Ríos C; de la Cruz VP; Torres-Ramos M
BMC Complement Altern Med; 2013 Oct; 13():262. PubMed ID: 24119308
[TBL] [Abstract][Full Text] [Related]
23. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
24. Systemic administration of l-kynurenine sulfate induces cerebral hypoperfusion transients in adult C57Bl/6 mice.
Varga DP; Menyhárt Á; Puskás T; Bari F; Farkas E; Kis Z; Vécsei L; Toldi J; Gellért L
Microvasc Res; 2017 Nov; 114():19-25. PubMed ID: 28546077
[TBL] [Abstract][Full Text] [Related]
25. Kynurenic acid and kynurenine aminotransferase in heart.
Baran H; Amann G; Lubec B; Lubec G
Pediatr Res; 1997 Mar; 41(3):404-10. PubMed ID: 9078543
[TBL] [Abstract][Full Text] [Related]
26. Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection.
Sas K; Szabó E; Vécsei L
Molecules; 2018 Jan; 23(1):. PubMed ID: 29342113
[TBL] [Abstract][Full Text] [Related]
27. Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.
Ishii K; Ogaya T; Song Z; Iizuka H; Fukushima T
Chirality; 2010 Nov; 22(10):901-6. PubMed ID: 20872665
[TBL] [Abstract][Full Text] [Related]
28. Subchronic
Blanco Ayala TB; Ramírez Ortega DR; Ovalle Rodríguez PO; Pineda B; Pérez de la Cruz GP; González Esquivel DG; Schwarcz R; Sathyasaikumar KV; Jiménez Anguiano AJ; Pérez de la Cruz VP
Antioxidants (Basel); 2021 Jan; 10(2):. PubMed ID: 33498402
[TBL] [Abstract][Full Text] [Related]
29. Acute liver failure increases kynurenic acid production in rat brain via changes in tryptophan metabolism in the periphery.
Sekine A; Fukuwatari T
Neurosci Lett; 2019 May; 701():14-19. PubMed ID: 30738081
[TBL] [Abstract][Full Text] [Related]
30. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
31. L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat.
Wu HQ; Lee SC; Scharfman HE; Schwarcz R
Exp Neurol; 2002 Sep; 177(1):222-32. PubMed ID: 12429224
[TBL] [Abstract][Full Text] [Related]
32. Perinatal kynurenine pathway metabolism in the normal and asphyctic rat brain.
Ceresoli-Borroni G; Schwarcz R
Amino Acids; 2000; 19(1):311-23. PubMed ID: 11026502
[TBL] [Abstract][Full Text] [Related]
33. Assessment of oxidative stress and activities of antioxidant enzymes depicts the negative systemic effect of iron-containing fertilizers and plant phenolic compounds in the desert locust.
Renault D; Dorrah MA; Mohamed AA; Abdelfattah EA; Bassal TT
Environ Sci Pollut Res Int; 2016 Nov; 23(21):21989-22000. PubMed ID: 27539469
[TBL] [Abstract][Full Text] [Related]
34. Fluorimetric assay for D-amino acid oxidase activity in rat brain homogenate by using D-kynurenine as a substrate.
Kozaki A; Iwasa S; Hosoda S; Nishiguchi Y; Nakayama M; Ichiba H; Fukushima T
Biosci Trends; 2012 Oct; 6(5):241-7. PubMed ID: 23229117
[TBL] [Abstract][Full Text] [Related]
35. Role of kynurenines in the central and peripheral nervous systems.
Németh H; Toldi J; Vécsei L
Curr Neurovasc Res; 2005 Jul; 2(3):249-60. PubMed ID: 16181118
[TBL] [Abstract][Full Text] [Related]
36. Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.
Carrillo-Mora P; Méndez-Cuesta LA; Pérez-De La Cruz V; Fortoul-van Der Goes TI; Santamaría A
Behav Brain Res; 2010 Jul; 210(2):240-50. PubMed ID: 20219555
[TBL] [Abstract][Full Text] [Related]
37. Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after D-kynurenine infusion: an in vivo microdialysis study.
Ogaya T; Song Z; Ishii K; Fukushima T
Neurochem Res; 2010 Apr; 35(4):559-63. PubMed ID: 19941066
[TBL] [Abstract][Full Text] [Related]
38. Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy.
Żarnowska I; Wróbel-Dudzińska D; Tulidowicz-Bielak M; Kocki T; Mitosek-Szewczyk K; Gasior M; Turski WA
Seizure; 2019 Jul; 69():265-272. PubMed ID: 31129366
[TBL] [Abstract][Full Text] [Related]
39. Kynurenine and its metabolites--kynurenic acid and anthranilic acid are associated with soluble endothelial adhesion molecules and oxidative status in patients with chronic kidney disease.
Pawlak K; Kowalewska A; Mysliwiec M; Pawlak D
Am J Med Sci; 2009 Oct; 338(4):293-300. PubMed ID: 19745702
[TBL] [Abstract][Full Text] [Related]
40. Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.
Oxenkrug G; van der Hart M; Roeser J; Summergrad P
Integr Clin Med; 2017; 1(1):. PubMed ID: 28748226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
